Company intelligence / Profile preview
Beacon Pharmaceuticals
- Ownership
- Private
- Employees
- ~2571
- Development stage
- Other
Overview
Beacon Pharmaceuticals is the leading oncology and generic drug manufacturer in Bangladesh, with more than 200 generic medicines and 65+ oncology drugs marketed and exported. The company also introduces 15–20 new high-tech products annually, and is known for launching global first generics (the first generic version available worldwide for some molecules), such as generic osimertinib, brigatinib, and more.
- Therapeutic areas
- EndocrinologyInfectious DiseasesHematologyCardiovascularOncologyNeurology
- Modalities
- Small moleculeMonoclonal antibodyBiologicNanoparticle
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Beacon Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beacon Pharmaceuticals.